Skip to main content
Clinical Trials/CTRI/2021/11/038136
CTRI/2021/11/038136
Not yet recruiting
未知

Evaluation of the role of N-acetyl cysteine (NAC) in Novel Corona Virus infection (COVID-19): A proof of concept study - COVINAC

Rajiv Gandhi University of Health Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Rajiv Gandhi University of Health Sciences
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Hospitalized adult age 18 to 70 years
  • 2\.Laboratory\-confirmed SARS\-CoV\-2 infection as determined by polymerase chain reaction (PCR) or other commercial or public health assay
  • 3\.Moderate Covid\-19 patients not requiring organ support
  • 4\.Mild Covid requiring hospitalization
  • 5 Duration of Hospital less than 48 hours.

Exclusion Criteria

  • 1\. Unlikely to survive after 48 hours from screening or unlikely to remain at the investigational site beyond 48 hours
  • 2\. Requiring organ support at screening (Organ support defined as need for ICU care, mechanical ventilation, Non Invasive Ventilation (NIV), High flow Nasal Oxygen at screening
  • 3\. Participation in any other clinical trial of an experimental treatment for COVID\-19
  • 4\. Known hypersensitivity to the trial drug or its components
  • 5\. Pregnant women or women who are breastfeeding
  • 6\. Consideration by the investigator, for any reason, that the subject is an unsuitable candidate to receive study treatment
  • 7\. Unable to provide consent

Outcomes

Primary Outcomes

Not specified

Similar Trials